Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 302
Gene Symbol: ANXA2
ANXA2
0.010 AlteredExpression disease BEFREE Immunohistochemistry assays indicated the expression level of AnxA2 was significantly higher in recurrent AdaCPs compared with primary ones. 27640198 2017
Entrez Id: 12
Gene Symbol: SERPINA3
SERPINA3
0.010 Biomarker disease BEFREE The bottom-up approach pointed out several proteins of the inflammation (namely, α2-HS-glycoprotein, α1-antichymotrypsin and apolipoproteins) as possibly involved in the genesis and growth of the cystic component of ACP. 28414889 2017
Entrez Id: 197
Gene Symbol: AHSG
AHSG
0.010 Biomarker disease BEFREE The bottom-up approach pointed out several proteins of the inflammation (namely, α2-HS-glycoprotein, α1-antichymotrypsin and apolipoproteins) as possibly involved in the genesis and growth of the cystic component of ACP. 28414889 2017
Entrez Id: 650
Gene Symbol: BMP2
BMP2
0.010 Biomarker disease BEFREE Bmp2 also significantly induced the calcification of ACP, and noggin inhibited this calcium deposition. 27983534 2017
Entrez Id: 6657
Gene Symbol: SOX2
SOX2
0.010 Biomarker disease BEFREE Expression of oncogenic β-catenin in Sox2+ young adult pituitary stem cells leads to formation of clusters of stem cells and induction of tumours resembling human adamantinomatous craniopharyngioma (ACP), derived from Sox2- cells in a paracrine manner. 29180744 2017
Entrez Id: 3620
Gene Symbol: IDO1
IDO1
0.010 AlteredExpression disease BEFREE In addition to IL-10, the established immunosuppressive factor IDO-1 was overexpressed by ACPs at the mRNA and protein levels. 28859336 2017
Entrez Id: 10631
Gene Symbol: POSTN
POSTN
0.010 AlteredExpression disease BEFREE It was found that POSTN expression increased in ACP-associated fibroblasts. 26723972 2016
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.010 Biomarker disease BEFREE Dysregulation of epidermal growth factor receptor (EGFR) and of sonic hedgehog (SHH) signaling in ACP suggest that paracrine oncogenic mechanisms may underlie ACP growth and implicate these signaling pathways as potential targets for therapeutic intervention using directed therapies. 27903126 2016
Entrez Id: 7852
Gene Symbol: CXCR4
CXCR4
0.010 AlteredExpression disease BEFREE High levels of CXCL12 and CXCR4 expression were associated with ACP recurrence. 24934367 2014
Entrez Id: 6387
Gene Symbol: CXCL12
CXCL12
0.010 AlteredExpression disease BEFREE High levels of CXCL12 and CXCR4 expression were associated with ACP recurrence. 24934367 2014
Entrez Id: 8842
Gene Symbol: PROM1
PROM1
0.010 AlteredExpression disease BEFREE Overall expression of CD44 was significantly decreased in adaCP versus papCP, whereas CD133 showed significantly higher protein and mRNA levels in adaCP. 24356780 2014
Entrez Id: 960
Gene Symbol: CD44
CD44
0.010 AlteredExpression disease BEFREE Overall expression of CD44 was significantly decreased in adaCP versus papCP, whereas CD133 showed significantly higher protein and mRNA levels in adaCP. 24356780 2014
Entrez Id: 1056
Gene Symbol: CEL
CEL
0.010 GeneticVariation disease BEFREE We observed no statistical significant associations between CEL VNTR allele frequencies and ACP or ICP. 23395566 2013
Entrez Id: 1571
Gene Symbol: CYP2E1
CYP2E1
0.010 AlteredExpression disease BEFREE Significant increases in CYP2E1 mRNA and protein expression were observed in freshly prepared blood lymphocytes isolated from ACs and ACP patients as compared with respective NACs or NACP patients. 20843640 2011
Entrez Id: 8932
Gene Symbol: MBD2
MBD2
0.010 AlteredExpression disease BEFREE A concomitant increase in N-nitrosodimethyamine demethylase activity was evident in the blood lymphocytes of ACs and ACP patients. 20843640 2011
Entrez Id: 2247
Gene Symbol: FGF2
FGF2
0.010 AlteredExpression disease BEFREE The expression of basic fibroblast growth factor and transforming growth factor beta was significantly higher in ACPs than in chronic rhinosinusitis and healthy mucosa. 16955781 2006
Entrez Id: 1080
Gene Symbol: CFTR
CFTR
0.010 GeneticVariation disease BEFREE Three mutations of CFTR were detected in four ACP patients with a prevalence (8.9%) not significantly different from that observed (3.0%) in ALD patients and from that expected (3.2%) in our geographical area. 12939655 2003
Entrez Id: 6690
Gene Symbol: SPINK1
SPINK1
0.010 GeneticVariation disease BEFREE One ACP patient (2.2%) was found to carry the most common mutation (N34S) of SPINK1 compared to none of the ALD patients (P=NS). 12939655 2003
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.030 AlteredExpression disease BEFREE Significantly increased levels of IL-6 and IL-10 were found in ACP compared with control. 31249603 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.030 Biomarker disease BEFREE While there is evidence to suggest that interleukin‑6 (IL‑6) induces craniopharyngioma (CP)‑associated inflammation, particularly in ACP, the role of IL‑6 in the progression of ACP remains unclear. 28487953 2017
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.030 Biomarker disease BEFREE Cytokines and chemokines with particularly elevated concentrations in ACPs were IL-6, CXCL1 (GRO), CXCL8 (IL-8) and the immunosuppressive cytokine IL-10. 28859336 2017
Entrez Id: 4706
Gene Symbol: NDUFAB1
NDUFAB1
0.040 Biomarker disease BEFREE In this study, we have investigated the influence of the quaternary structure of 2-trans-enoyl-ACP (CoA) reductase or InhA, from Mycobacterium tuberculosis, to its flexibility. 31548581 2019
Entrez Id: 60502
Gene Symbol: CPAT1
CPAT1
0.040 Biomarker disease BEFREE In this study, we have investigated the influence of the quaternary structure of 2-trans-enoyl-ACP (CoA) reductase or InhA, from Mycobacterium tuberculosis, to its flexibility. 31548581 2019
Entrez Id: 4706
Gene Symbol: NDUFAB1
NDUFAB1
0.040 Biomarker disease BEFREE In the absence of FXN, the NFS1-ISD11-ACP (SDA) complex was reportedly inhibited by binding of recombinant ISCU. 30031876 2018
Entrez Id: 60502
Gene Symbol: CPAT1
CPAT1
0.040 Biomarker disease BEFREE In the absence of FXN, the NFS1-ISD11-ACP (SDA) complex was reportedly inhibited by binding of recombinant ISCU. 30031876 2018